What are the advantages of tofacitinib/Shangjie’s targeted therapy?

Tofacitinib (Tofacitinib) is an oral small molecule targeted drug that mainly exerts an immune regulatory effect by inhibiting the Janus kinase (JAK) pathway. This pathway plays a key role in the development of a variety of inflammatory diseases and autoimmune diseases. Therefore, tofacitinib can effectively reduce inflammatory responses and excessive activation of the immune system by accurately intervening in the signaling link. Compared with traditional broad-spectrum immunosuppressants, its selectivity in pharmacological mechanisms gives it unique advantages.

First, a significant advantage of tofacitinib is the convenience of oral administration. Traditional treatments, such as certain biological agents, require intravenous infusion or subcutaneous injection, which results in poor patient compliance. However, tofacitinib is provided in the form of oral tablets, making long-term use more acceptable. This is particularly important in scenarios where chronic diseases such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis(UC), ankylosing spondylitis, etc. require continuous treatment.

Secondly, by blocking the signal transduction of key molecules in the JAK-STAT pathway, it can affect multiple inflammatory factors at the same time, rather than just targeting a single target. This "multi-pathway inhibition" characteristic enables tofacitinib to show strong efficacy in controlling disease activity, especially for some patient groups who have poor response to traditional DMARDs or biological agents, and can provide new treatment options.

In addition, tofacitinib also has certain advantages in its onset of effect. Clinical practice shows that some patients can experience improvements in joint pain, swelling or intestinal symptoms in a relatively short period of time, which is of great significance in alleviating the quality of life burden caused by the disease. At the same time, the blood concentration and metabolism characteristics of the drug are relatively clear, and the dosage can be adjusted for treatment, which is of particular concern under the trend of precision medicine.

In general, the advantages of tofacitinib/Shangjie’s targeted therapy are mainly reflected in the convenience of oral administration, multi-pathway mechanism of action, faster onset of action and expanded scope of application.

Reference materials:https://www.xeljanz.com/